Dr. Daniel Robert Foitl, MD

Dr. Foitl practices at Sutton Place Dermatology in New York, New York.

Dr. Foitl's NPI, 1861499147, was assigned on July 1, 2005. Dr. Foitl graduated from New York University School of Medicine in 1986. Dr. Foitl holds New York license 175720.

Dr. Foitl's primary practice is Sutton Place Dermatology, at 445 E 58th St, New York, NY 10022-2384. The practice phone is (212) 838-0270.

Dr. Foitl's primary practice is Sutton Place Dermatology in New York, New York. The medical group on file is Sutton Place Dermatology. Dmand AI also links Dr. Foitl to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Foitl practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Foitl's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Foitl is board certified in dermatology by the American Board of Dermatology. Dr. Foitl is licensed in New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Foitl treats.

CMS data shows 4,242 Medicare services from Dr. Foitl across 20 procedure codes in 2024, for 624 Medicare patients. Medicare paid $218,841 for them. Every service was in an office.

CMS counts 624 Medicare patients who saw Dr. Foitl in 2024. The largest group is 75 to 84, with 309 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Foitl's median patient age at 62, with 43% women.

In 2024, Dr. Foitl wrote 1,361 Medicare Part D claims for 389 patients. 89% of them were for generic drugs. CMS names the drug for 1,138 of them, across 19 drugs with 11 or more claims each, at $91,827 in total drug cost. In 2023, CMS named 1,023 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Foitl for performance year 2024, reported individually. Dr. Foitl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 430 procedures of skin biopsy by Dr. Foitl, more than 94% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 823 general payments to Dr. Foitl from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $2,061.

Dr. Foitl graduated from New York University School of Medicine in 1986.

Dr. Foitl is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.